Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Brunt AM"'
Autor:
Wheatley, D, Haviland, J, Patel, J, Sydenham, M, Alhasso, A, Chan, C, Cleator, S, Coles, C, Donovan, E, Kirby, A, Kirwan, C, Nabi, Z, Sawyer, E, Somaiah, N, Syndikus, I, Venables, K, Yarnold, J, Brunt, AM, Bliss, J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ffb570c1f6a5c815fb58567b4d70baa9
Autor:
Coles, C, Haviland, JS, Kirby, AM, Bhattacharya, I, Brunt, AM, Chan, C, Donovan, EM, Eaton, DJ, Griffin, CL, Hopwood, P, Jefford, ML, Lightowlers, S, Rajapakse, C, Sawyer, E, Stones, L, Syndikus, I, Titley, JC, Tsang, Y, Twyman, NI, Bliss, JM, Yarnold, JR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::9bb21069d71a88c0e1c92e625ef55007
Autor:
Brunt, AM, Haviland, JS, Wheatley, DA, Sydenham, MA, Alhasso, A, Bloomfield, D, Chan, C, Churn, M, Cleator, S, Coles, CE, Emson, M, Goodman, A, Harnett, A, Hopwood, P, Kirby, AM, Kirwan, C, Morris, C, Nabi, Z, Sawyer, E, Somaiah, N, Stones, L, Syndikus, I, Wilcox, M, Bliss, JM, Yarnold, JR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::363f46fbdd22c1b04d17dfad9580f4d6
Autor:
Fernando, IN, Bowden, SJ, Herring, K, Brookes, CL, Ahmed, I, Marshall, A, Grieve, R, Churn, M, Spooner, D, Latief, TN, Agrawal, RK, Brunt, AM, Stevens, A, Goodman, A, Canney, P, Bishop, J, Ritchie, D, Dunn, J, Poole, CJ, Rea, DW, SECRAB Investigators
Publikováno v:
Radiotherapy and Oncology
Highlights • SECRAB is the largest chemo-radiotherapy trial to date in early breast cancer. • SECRAB showed a positive therapeutic benefit of using adjuvant synchronous chemo-radiotherapy. • Synchronous chemo-radiotherapy should be used for ≤
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fae437c9b9b62e3ad5bac165a27192c1
Autor:
Coles, CE, Griffin, CL, Kirby, AM, Titley, J, Agrawal, RK, Alhasso, A, Bhattacharya, IS, Brunt, AM, Ciurlionis, L, Chan, C, Donovan, EM, Emson, MA, Harnett, AN, Haviland, JS, Hopwood, P, Jefford, ML, Kaggwa, R, Sawyer, EJ, Syndikus, I, Tsang, YM, Wheatley, DA, Wilcox, M, Yarnold, JR, Bliss, JM, Trialists, IMPORT
BACKGROUND: Local cancer relapse risk after breast conservation surgery followed by radiotherapy has fallen sharply in many countries, and is influenced by patient age and clinicopathological factors. We hypothesise that partial-breast radiotherapy r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::0d6bfce4f3a1b85c4a7f64e7ed042332
Autor:
Cameron, D, Morden, JP, Canney, P, Velikova, G, Coleman, R, Bartlett, J, Agrawal, R, Banerji, J, Bertelli, G, Bloomfield, D, Brunt, AM, Earl, H, Ellis, P, Gaunt, C, Gillman, A, Hearfield, N, Laing, R, Murray, N, Couper, N, Stein, RC, Verrill, M, Wardley, A, Barrett-Lee, P, Bliss, JM
Publikováno v:
Cameron, D, Morden, J P, Canney, P, Velikova, G, Coleman, R, Bartlett, J, Agrawal, R, Banerji, J, Bertelli, G, Bloomfield, D, Brunt, A M, Earl, H, Ellis, P, Gaunt, C, Gillman, A, Hearfield, N, Laing, R, Murray, N, Couper, N, Stein, R C, Verrill, M, Wardley, A & Barrett-Lee, P & Bliss, J M 2017, ' Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial ', The Lancet Oncology, vol. 18, no. 7, pp. 929-945 . https://doi.org/10.1016/S1470-2045(17)30404-7
The Lancet. Oncology
The Lancet. Oncology
Background: Adjuvant chemotherapy for early breast cancer has improved outcomes but causes toxicity. The UK TACT2 trial used a 2×2 factorial design to test two hypotheses: whether use of accelerated epirubicin would improve time to tumour recurrence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::98862457e205f943959621d3d081de3d
https://pubmed.ncbi.nlm.nih.gov/28677561
https://pubmed.ncbi.nlm.nih.gov/28677561
Autor:
Pinhel, I, Hills, M, Drury, S, Salter, J, Sumo, G, A'Hern, R, Bliss, JM, Sestak, I, Cuzick, J, Barrett-Lee, P, Harris, A, Dowsett, M, Bliss, M, Johnson, L, Lawrence, D, Price, D, Peto, J, Yarnold, J, Brunt, AM, Dodwell, D, Earl, H, Fernando, I, Foster, L, George, WD, Harnett, AM, Perren, T, Poole, C, Raina, V, Robinson, A
Introduction: Estrogen receptor-α (ER) and human epidermal growth factor receptor 2 (HER2) positivity are inversely correlated by standard criteria. However, we investigated the quantitative relation between ER and HER2 expression at both RNA and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::56835686ac8a7a5be8f3b4e092238bc1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.